Close

More on MRK

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-92.6% Growth)
- Ratings (7.9 Score)
- Holders
- Dividends (2.9% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (2/1/24)
- Ex-Dividend (12/14/2023)
- M&A (6/30/19 *Est)
- M&A (6/30/21 *Est)
- M&A (3/31/23 *Est)
- M&A (9/30/23 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Merck (NY:MRK)
Delayed: 105.63 -0.6 (0.56%)
Prev. Close $106.23  
Open$106.25 
52 Wk High$65.46 
52 Wk Low$47.97 
Day High$106.57 
Day Low$105.43 
P/E 71.86  
EPS$1.47 
Volume9,954,926 

Friends, Peers and Foes (?): MRNA, MKKGY, , RXDX, PFE (more...)

Dec 5, 2023 02:00 PM MilliporeSigma Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis
Dec 4, 2023 04:48 PM U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.11%
Nov 30, 2023 05:00 PM FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) for the First-Line Treatment of Patients With Locally Advanced or Metastatic
Nov 29, 2023 09:00 AM AWS and Accenture Help Merck Use Cloud Technology to Reduce Drug Discovery Time and Accelerate Clinical Trial Development
Nov 29, 2023 07:49 AM Merck (MRK) PT Raised to $131 at Jefferies
Nov 28, 2023 04:52 PM Form 8-K Merck & Co., Inc. For: Nov 21
Nov 28, 2023 04:36 PM U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.24%
Nov 28, 2023 01:21 PM Merck (MRK) Raises Quarterly Dividend 5.5% to $0.77; 3.1% Yield
Nov 28, 2023 01:17 PM Merck Announces First-Quarter 2024 Dividend
Nov 28, 2023 06:48 AM Merck (MRK) STRIDE-3 Trial of V116 Vaccine Demonstrated Superior Immunogenicity vs PCV20 in Older Adults
View All Articles

Entities mentioned with MRK

View All Entities